Currently, there are 328.44M common shares owned by the public and among those 319.90M shares have been available to trade.
However, the script later moved the day high at 11.95, down -1.92%. The company’s stock has a 5-day price change of 1.62% and 5.73% over the past three months. BILI shares are trading -7.48% year to date (YTD), with the 12-month market performance down to -47.38% lower. It has a 12-month low price of $8.80 and touched a high of $21.92 over the same period. BILI has an average intraday trading volume of 7.43 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.08%, 4.62%, and -13.19% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bilibili Inc ADR (NASDAQ: BILI) shares accounts for 18.01% of the company’s 328.44M shares outstanding.
It has a market capitalization of $3.60B and a beta (3y monthly) value of 1.00. The earnings-per-share (ttm) stands at -$1.64. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.32% over the week and 3.61% over the month.
Earnings per share for the fiscal year are expected to increase by 78.85%, and 216.21% over the next financial year.
Looking at the support for the BILI, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on March 11, 2024, with the firm’s price target at $10-$11. Citigroup coverage for the Bilibili Inc ADR (BILI) stock in a research note released on March 11, 2024 offered a Neutral rating with a price target of $12.50. Daiwa Securities was of a view on January 19, 2024 that the stock is Neutral, while UBS gave the stock Neutral rating on December 04, 2023, issuing a price target of $22- $13.20. Barclays on their part issued Underweight rating on November 30, 2023.
